Douglas Fearon
Douglas Fearon
Unknown affiliation
Verified email at
Cited by
Cited by
The instructive role of innate immunity in the acquired immune response
DT Fearon, RM Locksley
Science 272 (5258), 50-54, 1996
T cell exclusion, immune privilege, and the tumor microenvironment
JA Joyce, DT Fearon
Science 348 (6230), 74-80, 2015
A framework for advancing our understanding of cancer-associated fibroblasts
E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ...
Nature Reviews Cancer 20 (3), 174-186, 2020
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
C Feig, JO Jones, M Kraman, RJB Wells, A Deonarine, DS Chan, ...
Proceedings of the National Academy of Sciences 110 (50), 20212-20217, 2013
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
D Íhlund, A Handly-Santana, G Biffi, E Elyada, AS Almeida, ...
Journal of Experimental Medicine 214 (3), 579-596, 2017
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
PW Dempsey, MED Allison, S Akkaraju, CC Goodnow, DT Fearon
Science 271 (5247), 348-350, 1996
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
JD Fingeroth, JJ Weis, TF Tedder, JL Strominger, PA Biro, DT Fearon
Proceedings of the National Academy of Sciences 81 (14), 4510-4514, 1984
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
HF Weisman, T Bartow, MK Leppo, HC Marsh Jr, GR Carson, MF Concino, ...
Science 249 (4965), 146-151, 1990
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein–α
M Kraman, PJ Bambrough, JN Arnold, EW Roberts, L Magiera, JO Jones, ...
Science 330 (6005), 827-830, 2010
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
J Albrengues, MA Shields, D Ng, CG Park, A Ambrico, ME Poindexter, ...
Science 361 (6409), eaao4227, 2018
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte
DT Fearon
The Journal of experimental medicine 152 (1), 20-30, 1980
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes
RH Carter, DT Fearon
Science 256 (5053), 105-107, 1992
Control of the amplification convertase of complement by the plasma protein beta1H.
JM Weiler, MR Daha, KF Austen, DT Fearon
Proceedings of the National Academy of Sciences 73 (9), 3268-3272, 1976
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
A Nicholson-Weller, J Burge, DT Fearon, PF Weller, KF Austen
Journal of immunology (Baltimore, Md.: 1950) 129 (1), 184-189, 1982
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP
GM Doody, LB Justement, CC Delibrias, RJ Matthews, J Lin, ML Thomas, ...
Science 269 (5221), 242-244, 1995
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
DT Fearon, KF Austen
The Journal of experimental medicine 142 (4), 856-863, 1975
Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
J Tanner, J Weis, D Fearon, Y Whang, E Kieff
Cell 50 (2), 203-213, 1987
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)
JM Ahearn, DT Fearon
Advances in immunology 46, 183-219, 1989
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
DT Fearon, MC Carroll, MC Carroll
Annual review of immunology 18 (1), 393-422, 2000
The system can't perform the operation now. Try again later.
Articles 1–20